Brief report: Autoantibodies against erythropoietin in a patient with pure red-cell aplasia

New England Journal of Medicine

Volumn 334, Issue 10, 1996, Pages 630-633

  Casadevall, Nicole ^a,d   Dupuy, Evelyne ^b   Molho Sabatier, Pascale ^b   Tobelem, Gérard ^b   Varet, Bruno ^c   Mayeux, Patrick ^e  

^a RAYMOND POINCARÉ HOSPITAL   (France)

^b HÔPITAL LARIBOISIÈRE   (France)

^c HÔPITAL NECKER ENFANTS MALADES   (France)

^d INSERM   (France)

^e INSTITUT COCHIN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; ERYTHROPOIETIN;

AGED; ANTIBODY DETECTION; ARTICLE; BONE MARROW CULTURE; CASE REPORT; CLINICAL FEATURE; CONTROLLED STUDY; COOMBS TEST; FEMALE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PURE RED CELL ANEMIA; BLOOD; BONE MARROW; BONE MARROW CELL; IMMUNOLOGY; METABOLISM;

AGED; AUTOANTIBODIES; BONE MARROW; BONE MARROW CELLS; ERYTHROPOIETIN; FEMALE; HUMANS; RED-CELL APLASIA, PURE;

EID: 0030573330     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199603073341004     Document Type: Article

References (30)

1. Dessypris EN The biology of pure red cell aplasia Semin Hematol 1991, 28:275-84
2. Krantz SB Pure red-cell aplasia. N Engl J Med 1974;291:345-50.
3. DiGiacomo J, Furst SW, Nixon DD Primary acquired red cell aplasia in the adult. J Mount Sinai Hosp NY 1966,33:382-95.
4. Krantz SB, Kao V. Studies on red cell aplasia. II. Report of a second patient with an antibody to erythroblast nuclei and a remission after immunosuppressive therapy. Blood 1969;34:1-13.
5. Francis DA. Pure red-cell aplasia. association with systemic lupus erythematosus and primary autoimmune hypothyroidism. BMJ 1982;284:85-8.
6. Barnes RD. Refractory anaemia with thymoma. Lancet 1966,2.1464.
7. Krantz SB, Kao V. Studies on red cell aplasia. I Demonstration of a plasma inhibitor to heme synthesis and an antibody to erythroblast nuclei Proc Natl Acad Sci U S A 1967;58:493-500.
8. Eisemann G, Dameshek W. Splenectomy for "pure red-cell" hypoplastic (aregenerative) anemia associated with autoimmune hemolytic disease N Engl J Med 1954;251:1044-8.
9. Lacombe C, Casadevall N, Muller O, Varet B. Erythroid progenitors in adult chronic pure red cell aplasia relationship of in vitro erythroid colonies to therapeutic response. Blood 1984;64:71-7.
10. Marmont A, Peschle C, Sanguineti M, Condorelli M Pure red cell aplasia (PRCA): response of three patients to cyclophosphamide and/or antilymphocyte globulin (ALG) and demonstration of two types of serum IgG inhibitors to erythropoiesis. Blood 1975;45:247-61.
11. Krantz SB. Studies on red cell aplasia. 3. Treatment with horse antihuman thymocyte gamma globulin Blood 1972;39.347-60.
12. Zaentz SD, Krantz SB. Brown EB. Studies on pure red cell aplasia: maintenance therapy with immunosuppressive drugs. Br J Haematol 1976;32:47-54.
13. Khelif A, Van HV, Tremisi JP, et al. Remission of acquired pure red cell aplasia following plasma exchanges Scand J Haematol 1985;34:13-5.
14. Messner HA, Fauser AA, Curtis JE, Dotten D. Control of antibody-mediated pure red-cell aplasia by plasmapheresis N Engl J Med 1981,304:1334-8
15. Krantz SB, Moore WH, Zaentz SD. Studies on red cell aplasia. V. Presence of erythroblast cytotoxicity in G-globulin fraction of plasma. J Clin Invest 1973;52:324-36.
16. Zaentz SD, Krantz SB. Studies on pure red cell aplasia. VI Development of two-stage erythroblast cytotoxicity method and role of complement. J Lab Clin Med 1973,82.31-43.
17. Maung ZT, Norden J, Middleton PG, Jack FR, Chandler JE Pure red cell aplasia: further evidence of T cell clonal disorder. Br J Haematol 1994;87: 189-92.
18. Mangan KF, Volkin R, Winkelstein A Autoreactive erythroid progenitor-T suppressor cells in the pure red cell aplasia associated with thymoma and panhypogammaglobulincmia. Am J Hematol 1986;23:167-73.
19. Hoffman R, Kopel S, Hsu SD. Dainiak N, Zanjani ED. T cell chronic lymphocytic leukemia- presence in bone marrow and peripheral blood of cells that suppress erythropoiesis in vitro. Blood 1978;52:255-60
20. Nagasawa T, Abe T, Nakagawa T. Pure red cell aplasia and hypogammaglobulinemia associated with Tr-cell chronic lymphocytic leukemia. Blood 1981;57:1025-31.
21. Mangan KF, D'Alessandro L. Hypoplastic anemia in B cell chronic lymphocytic leukemia: evolution of T cell-mediated suppression of erythropoiesis in early-stage and late-stage disease Blood 1985;66:533-41.
22. Jepson JH, Lowenstein L. Panhypoplasia of the bone marrow I. Demonstration of a plasma factor with anti-crythropoietin-like activity. Can Med Assoc J 1968,99:99-101.
23. Peschle C, Marmont AM, Marone G, Genovese A, Sasso GF, Condorelli M. Pure red cell aplasia studies on an IgG serum inhibitor neutralizing erythropoietin. Br J Haematol 1975,30.411-7.
24. McLeod DL, Shreeve MM, Axelrad AA. Improved plasma culture system for production of erythrocytic colonies in vitro: quantitative assay method for CFU-E. Blood 1974;44:517-34
25. Mayeux P, Casadevall N, Lacombe C, Muller O, Tambourin P. Solubilization and hydrodynamic characteristics of the erythropoietin receptor: evidence for a multimeric complex Eur J Biochem 1990;194:271-8.
26. Mayeux P, Casadevall N, Muller O, Lacombe C. Glyeosylation of the murine erythropoietin receptor. FEBS Lett 1990;269:167-70.
27. Dordal MS, Wang FF, Goldwasscr E. The role of carbohydrate in erythropoietin action Endocrinology 1985;116.2293-9.
28. Komatsu N, Nakauchi H, Miwa A, et al. Establishment and characterization of a human leukemic cell line with megakaryocytic features dependency on granulocyte-macrophage colony-stimulating factor, interleukin-3, or erythropoietin for growth and survival. Cancer Res 1991;51:341-8.
29. Hermine O, Mayeux P, Titeux M, et al. Granulocyte-macrophage colonystimulating factor and erythropoietin act competitively to induce two different programs of differentiation in the human pluripotent cell line UT-7. Blood 1992;80:3060-9.
30. Dessypris EN, Krantz SB, Roloff JS, Lukens JN Mode of action of the IgG inhibitor of erythropoiesis in transient erythroblastopenia of children. Blood 1982;59.114-23.